Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 37 out of 100. Lewy body dementia

Topic: Brain proteins, microglia and lab models

• To clarify the key role of Muscone delayed the development of vascular dementia (VD). • To reveal synaptic function in VD associated with neuronal pentraxin receptor (NP2). • To reveal that Muscone alleviates VD through the BDNF-TrkB-NP2 signaling pathway initially. The objective of this study is to explore the mechanism by which Muscone treats VD. Cognitive function was evaluated by behavioral tests, cerebral blood flow(CBF) was detected with laser speckle imaging(LSI) on rat model induced by bilateral common carotid artery ligation(2-VO). To further elucidate the mechanism of Muscone acts on synaptic function, Mendelian randomization test was employed to identify neuronal pentraxin receptor (NPTXR) as a risk factor for VD. Subsequently, Oxygen and Glucose-Deprivation/Reoxygenation (OGD/R) model was established in HT22 cells. BDNF transfection, protein docking, and co-immunoprecipitation were utilized to validate whether the protective effect of Muscone is mediated through regulation of the BDNF-TrkB-NP2 pathway. Muscone significantly enhanced the cognitive performance, memory capacity in rats, promoted axonal growth and increased dendritic spine density. Muscone effectively improved cell survival rates, mitigated the accumulation of ROS and Ca 2+ following OGD/R treatment. Furthermore, Muscone led to a significant upregulation of synapse-associated proteins expression. Importantly, Muscone exhibited a notable ability to elevate BDNF levels, with subsequent binding with its downstream molecule TrkB to NP2. The activation of the BDNF-TrkB-NP2 pathway and synaptic function enhancement by Muscone contribute to its protective effect against VD injury. Therefore, our study uncovers a novel mechanism underlying the anti-VD properties of Muscone.

Key findings

Why it matters

In a rat model of vascular dementia and in HT22 cells, Muscone improved cognitive performance and synaptic measures via the BDNF-TrkB-NP2 pathway. These are animal and cell findings and do not yet show a treatment, cure or prevention in people.

Study details

How this study scored 37/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 2 of 7; Citations per year 2 of 5; Impact for its field and year 2 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 1 of 4; Institution's track record 0 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 37 of 100.37 of 100 points earned63 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (International Immunopharmacology)
Journal's citation record 2 / 4 International Immunopharmacology: journal h-index 165 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 2 / 7 Cited 9 times (OpenAlex, 2026-10-10)
Citations per year 2 / 5 3.0 citations a year over 3 year(s) since 2025
Impact for its field and year 2 / 6 Cited 2.7× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 9 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Ning Wang: h-index 19 (OpenAlex, whole career)
Institution's track record 0 / 3 Western Sydney University: institution h-index 499 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 2 institution(s) in 2 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 39923578)
Free to read 2 / 2 Free to read
Total 37 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

APA 7th

Huang, P., Sun, H., Chen, Y., Li, J., Peng, Y., Ge, C., et al. (2025). Muscone enhances synaptic function in vascular dementia through activating BDNF-TrkB-NP2 signaling pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114232

Vancouver

Huang P, Sun H, Chen Y, Li J, Peng Y, Ge C, et al. Muscone enhances synaptic function in vascular dementia through activating BDNF-TrkB-NP2 signaling pathway. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114232. PMID: 39923578.

BibTeX

@article{huang2025-39923578,
  author  = {Huang, Ping and Sun, Hao and Chen, Yuang and Li, Jiacheng and Peng, Yuqin and Ge, Chaowen and Zhu, Kai and Zhou, Xian and others},
  title   = {{Muscone enhances synaptic function in vascular dementia through activating BDNF-TrkB-NP2 signaling pathway}},
  journal = {International Immunopharmacology},
  year    = {2025},
  doi     = {10.1016/j.intimp.2025.114232},
  pmid    = {39923578},
  url     = {https://doi.org/10.1016/j.intimp.2025.114232}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Lewy body dementia

Also tagged “mice”

1,150 studies in the library carry the topic tag “mice”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,150 tagged studies.

Similar studies

More on Lewy body dementia

See all studies in Lewy body dementia →